These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 18467692)

  • 1. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes.
    Fein JA; Sokolow S; Miller CA; Vinters HV; Yang F; Cole GM; Gylys KH
    Am J Pathol; 2008 Jun; 172(6):1683-92. PubMed ID: 18467692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of synaptic terminals from Alzheimer's disease cortex.
    Sokolow S; Henkins KM; Williams IA; Vinters HV; Schmid I; Cole GM; Gylys KH
    Cytometry A; 2012 Mar; 81(3):248-54. PubMed ID: 22213704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional distribution of tau, beta-amyloid and beta-amyloid precursor protein in the Alzheimer's brain: a quantitative immunolabelling study.
    Shukla C; Bridges LR
    Neuroreport; 1999 Dec; 10(18):3785-9. PubMed ID: 10716210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer's cortical synapses.
    Henkins KM; Sokolow S; Miller CA; Vinters HV; Poon WW; Cornwell LB; Saing T; Gylys KH
    Brain Pathol; 2012 Nov; 22(6):826-33. PubMed ID: 22486774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal tau with seeding activity is released from Alzheimer's disease synapses, and seeding potential is associated with amyloid beta.
    Miyoshi E; Bilousova T; Melnik M; Fakhrutdinov D; Poon WW; Vinters HV; Miller CA; Corrada M; Kawas C; Bohannan R; Caraway C; Elias C; Maina KN; Campagna JJ; John V; Gylys KH
    Lab Invest; 2021 Dec; 101(12):1605-1617. PubMed ID: 34462532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
    Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P
    Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases.
    Bilousova T; Miller CA; Poon WW; Vinters HV; Corrada M; Kawas C; Hayden EY; Teplow DB; Glabe C; Albay R; Cole GM; Teng E; Gylys KH
    Am J Pathol; 2016 Jan; 186(1):185-98. PubMed ID: 26718979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease.
    Takata K; Kitamura Y; Nakata Y; Matsuoka Y; Tomimoto H; Taniguchi T; Shimohama S
    Am J Pathol; 2009 Jul; 175(1):17-24. PubMed ID: 19497998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.
    den Haan J; Morrema THJ; Verbraak FD; de Boer JF; Scheltens P; Rozemuller AJ; Bergen AAB; Bouwman FH; Hoozemans JJ
    Acta Neuropathol Commun; 2018 Dec; 6(1):147. PubMed ID: 30593285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
    Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
    Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.
    Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G
    Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.
    Sokolow S; Henkins KM; Bilousova T; Gonzalez B; Vinters HV; Miller CA; Cornwell L; Poon WW; Gylys KH
    J Neurochem; 2015 May; 133(3):368-79. PubMed ID: 25393609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain.
    Abad MA; Enguita M; DeGregorio-Rocasolano N; Ferrer I; Trullas R
    J Neurosci; 2006 Dec; 26(49):12735-47. PubMed ID: 17151277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex.
    Welikovitch LA; Do Carmo S; Maglóczky Z; Szocsics P; Lőke J; Freund T; Cuello AC
    Acta Neuropathol; 2018 Dec; 136(6):901-917. PubMed ID: 30362029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brain.
    Martin-Rehrmann MD; Hoe HS; Capuani EM; Rebeck GW
    Neurotox Res; 2005; 7(3):231-42. PubMed ID: 15897157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.
    Sokolow S; Luu SH; Nandy K; Miller CA; Vinters HV; Poon WW; Gylys KH
    Neurobiol Dis; 2012 Jan; 45(1):381-7. PubMed ID: 21914482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses.
    Takahashi RH; Capetillo-Zarate E; Lin MT; Milner TA; Gouras GK
    PLoS One; 2013; 8(1):e51965. PubMed ID: 23372648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.